HRMY
Harmony Biosciences Holdings Inc
Price:  
32.39 
USD
Volume:  
386,485.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRMY WACC - Weighted Average Cost of Capital

The WACC of Harmony Biosciences Holdings Inc (HRMY) is 7.2%.

The Cost of Equity of Harmony Biosciences Holdings Inc (HRMY) is 7.10%.
The Cost of Debt of Harmony Biosciences Holdings Inc (HRMY) is 9.30%.

Range Selected
Cost of equity 5.40% - 8.80% 7.10%
Tax rate 4.50% - 14.80% 9.65%
Cost of debt 4.60% - 14.00% 9.30%
WACC 5.3% - 9.1% 7.2%
WACC

HRMY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.34 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 8.80%
Tax rate 4.50% 14.80%
Debt/Equity ratio 0.1 0.1
Cost of debt 4.60% 14.00%
After-tax WACC 5.3% 9.1%
Selected WACC 7.2%